381 related articles for article (PubMed ID: 1654538)
1. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
2. Modification of nociception in a model of localized inflammatory pain by long-term administration of naloxone.
Millan MJ; Colpaert FC
Prog Clin Biol Res; 1990; 328():331-4. PubMed ID: 2154789
[TBL] [Abstract][Full Text] [Related]
3. The influence of sustained opioid receptor blockade in a model of long-term, localized inflammatory pain in rats.
Millan MJ; Colpaert FC
Neurosci Lett; 1990 May; 113(1):50-5. PubMed ID: 2164176
[TBL] [Abstract][Full Text] [Related]
4. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat.
Millan MJ; Morris BJ
Brain Res; 1988 May; 450(1-2):247-58. PubMed ID: 2841004
[TBL] [Abstract][Full Text] [Related]
5. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems.
Millan MJ; Członkowski A; Pilcher CW; Almeida OF; Millan MH; Colpaert FC; Herz A
J Neurosci; 1987 Jan; 7(1):77-87. PubMed ID: 3027278
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of mu and kappa opioid systems on motivational processes.
Shippenberg TS; Herz A
NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
[TBL] [Abstract][Full Text] [Related]
7. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
Stein C; Millan MJ; Yassouridis A; Herz A
Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
[TBL] [Abstract][Full Text] [Related]
9. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
10. Evidence that mu-opioid receptors mediate midbrain "stimulation-produced analgesia" in the freely moving rat.
Millan MJ; Członkowski A; Herz A
Neuroscience; 1987 Sep; 22(3):885-96. PubMed ID: 2825072
[TBL] [Abstract][Full Text] [Related]
11. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
[TBL] [Abstract][Full Text] [Related]
12. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.
Millan MJ; Członkowski A; Morris B; Stein C; Arendt R; Huber A; Höllt V; Herz A
Pain; 1988 Dec; 35(3):299-312. PubMed ID: 2906425
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin.
Stein C; Gramsch C; Herz A
J Neurosci; 1990 Apr; 10(4):1292-8. PubMed ID: 2158530
[TBL] [Abstract][Full Text] [Related]
14. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
[TBL] [Abstract][Full Text] [Related]
17. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
Herrero JF; Headley PM
Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
[TBL] [Abstract][Full Text] [Related]
19. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
20. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
